PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Clinical trials for PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME trials appear
Sign up with your email to follow new studies for PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to knock out tough blood cancers
Disease control Recruiting nowThis study is testing a combination of four chemotherapy drugs (cladribine, idarubicin, cytarabine, and venetoclax) to see how well they work against aggressive forms of blood cancer, including acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), and chronic my…
Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Immune-Targeting drug cocktail tested for rare blood disorders
Disease control Recruiting nowThis study is testing a combination of four drugs to see if they can improve blood counts in adults with aplastic anemia or low-risk myelodysplastic syndrome (MDS). The treatment aims to calm an overactive immune system that may be attacking the bone marrow, while also boosting w…
Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists unleash engineered virus to hunt down blood cancers
Disease control Recruiting nowThis early-stage trial is testing a new treatment for patients whose blood cancers have returned or not responded to standard therapies. The treatment uses a modified virus that is designed to selectively infect and kill cancer cells while sparing healthy ones. Researchers are st…
Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Custom immune cells fight blood cancers after transplant
Disease control Recruiting nowThis study tests a personalized immune cell therapy for patients with blood cancers like leukemia, lymphoma, and myeloma. After receiving chemotherapy and a cord blood transplant, patients get infusions of natural killer (NK) cells—immune cells that may kill remaining cancer cell…
Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC